Resistance of ALR/Lt islets to free radical-mediated diabetogenic stress is inherited as a dominant trait

Diabetes

Volumn 48, Issue 11, 1999, Pages 2189-2196

  Mathews, Clayton E ^a   Leiter, Edward H ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; ANTIOXIDANT; FREE RADICAL; GLUCOSE; INSULIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETOGENESIS; DISEASE PREDISPOSITION; DISEASE RESISTANCE; GENE CONTROL; GLUCOSE TRANSPORT; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; STRAIN DIFFERENCE; STRESS;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CROSSES, GENETIC; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FREE RADICALS; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE; IMMUNITY, NATURAL; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED STRAINS; SEX CHARACTERISTICS; SPECIES SPECIFICITY; TERT-BUTYLHYDROPEROXIDE;

EID: 0032710718     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.11.2189     Document Type: Article

References (38)

1. Ino T, Kawamoto Y, Sato K, Nishikawa K, Yamada A, Ishibashi K, Sekiguchi F: Selection of mouse strains showing high and low incidences of alloxan-induced diabetes. Jikken Dobutsu 40:61-67, 1991
2. Leiter EH, Gerling IC, Flynn JC: Spontaneous insulin dependent diabetes mellitus (IDDM) in nonobese diabetic (NOD) mice: comparisons with experimentally-induced IDDM. In Experimental Models of Diabetes. McNeill JH, Ed. Boca Raton, FL, CRC Press, 1999, p. 257-295
3. Sekiguchi F, Ishibashi K, Katoh H, Kawamoto Y, Ino T: Genetic profile of alloxan-induced diabetes-susceptible mice (ALS) and resistant mice (ALR). Exp Anim 39:269-272, 1990
4. Graser RT, Mathews CE, Leiter EH, Serreze DV: MHC characterization of ALR and ALS mice: respective similarities to the NOD and NON strains. Immunogenetics 49:722-726, 1999
5. Rabinovitch A: An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diab Metab Rev 14:129-151, 1998
6. Wolff SP: Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 49:642-652, 1993
7. Mathews CE, Leiter EH: Constitutive differences in anti-oxidant defense status distinguish alloxan resistant (ALR/Lt) and alloxan susceptible (ALS/Lt) mice. Free Radic Biol Med 27:449-455, 1999
8. Swenson F, Martinez C, Lazarow A: Blood glutathione and alloxan susceptibility in inbred mice. Proc Soc Exp Biol Med 100:6-8, 1959
9. Martinez C, Grande F, Bittner J: Alloxan diabetes in different strain of mice. Proc Soc Exp Biol Med 87:236-238, 1954
10. Cardinal JW, Allan DJ, Cameron DP: Differential metabolite accumulation may be the cause of strain sensitivity to streptozotocin-induced β-cell death in inbred mice. Endocrinology 139:2885-2891, 1998
11. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP: An improved method for the isolation of mouse pancreatic islets. Transplantation 40:437-438, 1985
12. Eizirik DL, Sandler S, Hallberg A, Bendtzen K, Sener A, Malaisse WJ: Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta. Endocrinology 125:752-759, 1989
13. Ablamunits V, Elias D, Reshef T, Cohen IR: Islet T cells secreting IFN gamma in NOD mouse: diabetes arrest by p277 peptide treatment. J Autoimmun 11:73-81, 1998
14. Suarez-Pinzon WL, Strynadka K, Rabinovitch A: Destruction of rat pancreatic islet beta-cells by cytokines involves the production of cytotoxic aldehydes. Endocrinology 137:5290-5296, 1996
15. Wang Z, Gleichmann H: GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 47:50-56, 1998
16. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Helleretrom C, Andersson A: Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci USA 91:9253-9256, 1994
17. Flodstrom M, Tyrberg B, Eizirik DL, Sandler S: Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 48:706-713, 1999
18. Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw B, Verma A, Wang Z-Q, Snyder SH: Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:3059-3064, 1999
19. Cornelius IG, Luttge BG, Peck AB: Anti-oxidant enzyme activities in IDD prone and IDD resistant mice: a comparative study. Free Radic Biol Med 14:409-420, 1993
20. Papaccio G, Frascatore S, Pisanti FA, Latronico MV, Linn T: Superoxide dismutase in the nonobese diabetic (NOD) mouse: a dynamic time-course study. Life Sci 56:2223-2228, 1995
21. Lenzen S, Drinkgern J, Tiedge M: Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20:463-466, 1996
22. Oberley LW: Free radicals and diabetes. Free Radic Biol Med 5:113-124, 1988
23. Ho E, Medeiros DM, Bray TM: Glutathione (GSH) inhibits activation of NF-kB, an oxidative stress response element in the pancreas and protects against alloxan-induced diabetes (Abstract). FASEB J 12:A815, 1998
24. Fischer LJ, Hamburger SA: Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase, and a metal chelator. Diabetes 29:213-216, 1980
25. Gandy SE, Buse MG, Crouch RK: Protective role of superoxide dismutase against diabetogenic drugs. J Clin Invest 70:650-658, 1982
26. Kubisch HM, Wang J, Bray TM, Phillips JP: Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes 46:1563-1566, 1997
27. Hohmeier H-E, Thigpen A, Tran VV, Davis R, Newgard C: Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101:1811-1820, 1998
28. Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J, Miyazaki J: Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and anti-apoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med 188:1445-1451, 1998
29. Rushmore TH, Morton MR, Pickett CB: The anti-oxidant response element activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 266:11632-11639, 1991
30. Ho Y-S, Howard AJ: Cloning and characterization of the rat glutathione peroxidase gene. FEBS Lett 301:5-9, 1992
31. Reimer DL, Bailley J, Shinh SM: Complete cDNA and 5′ genomic sequences and multilevel regulation of the mouse catalase gene. Genomics 21:325-336, 1994
32. Jones PL, Kucera G, Gordon H, Boss JM: Cloning and characterization of the murinemanganous superoxide dismutase-encoding gene. Gene 153:155-161, 1995
33. Phelan SA, Johnson KA, Beier DR, Paigen B: Characterization of the murine gene encoding Aop2 (antioxidant protein 2) and identification of two highly related genes. Genomics 54:132-139, 1998
34. Wasserman WW, Fahl WE: Comprehensive analysis of proteins which interact with the antioxidant responsive element correlation of ARE-BP-1 with the chemoprotective induction response. Arch Biochem Biophys 344:387-396, 1997
35. Wasserman WW, Fahl WE: Functional anti-oxidant response elements. Proc Natl Acad Sci U S A 94:5361-5366, 1997
36. Schwartz RH: T cell clonal anergy. Curr Opin Immunol 9:351-357, 1997
37. Watanabe Y, Kawakami K, Hirayama Y, Nagano K: Transcription factors positively and negatively regulating the Na,K-ATPase alpha 1 subunit gene. J Biochem Tokyo 114:849-855, 1993
38. Mathews CE, Graser RT, Serreze DV, Leiter EH: ALR/Lr Mice: β cell resistance to chemical and autoimmune attack associated with increased anti-oxidant defenses (Abstract). Diabetes 48 (Suppl. 1):A450-A451, 1999